Ustekinumab: “Real-world” outcomes and potential predictors of nonresponse in treatment-refractory Crohn’s disease

BACKGROUND: Ustekinumab was approved in Europe for the treatment of adults with moderate to severe Crohn's disease (CD) in 2016, and there is an urgent need for data on its everyday use. AIM: To obtain data on the daily use of ustekinumab. METHODS: This is a retrospective monocentric study. Pat...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:World J Gastroenterol
Main Authors: Hoffmann, Peter, Krisam, Johannes, Wehling, Cyrill, Kloeters-Plachky, Petra, Leopold, Yvonne, Belling, Nina, Gauss, Annika
Format: Artigo
Sprog:Inglês
Udgivet: Baishideng Publishing Group Inc 2019
Fag:
Retrospective Study
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6710179/
https://ncbi.nlm.nih.gov/pubmed/31496626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v25.i31.4481
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker